Effects of high blood glucose during pregnancy on children's language development
A Cohort Study on the Impact of Gestational Blood Glucose Management and Postnatal Nurturing Environment on Delayed Language Development in Children
This study looks at how high blood sugar during pregnancy affects the language development of children aged 1.5 to 2.5 years, especially for those whose mothers had gestational diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 1 Year to 3 Years |
| Sex | All |
| Sponsor | Gansu Provincial Maternal and Child Health Care Hospital Academic / other |
| Locations | 1 site (Lanzhou, Gansu) |
| Trial ID | NCT06021691 on ClinicalTrials.gov |
What this trial studies
This observational cohort study investigates how prenatal exposure to high blood glucose levels and postnatal nurturing environments affect language development in children aged 1.5 to 2.5 years. Mothers diagnosed with gestational diabetes will be monitored for their blood glucose management during pregnancy, and their children's language development will be assessed using various evaluation scales. The study aims to identify key factors that contribute to delayed language development, facilitating early detection and intervention strategies.
Who should consider this trial
Good fit: Ideal candidates include mothers with gestational diabetes and their children aged 1.5 to 2.5 years without serious underlying diseases.
Not a fit: Patients with diagnosed hearing impairments, neurological disorders, or other serious underlying conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved strategies for managing gestational diabetes and enhancing language development in children.
How similar studies have performed: While the specific approach of this study may be novel, similar studies have shown that prenatal factors can significantly impact child development outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children 1.5-2.5 years old with no serious underlying diseases and no hearing impairment. Exclusion Criteria: * diagnosed hearing impairment, organic dysarthria, oral disease; (ii) cerebral palsy; * neurological and hereditary metabolic diseases; (iv) deaf father/mother.
Where this trial is running
Lanzhou, Gansu
- GansuPMCH — Lanzhou, Gansu, China (Recruiting)
Study contacts
- Principal investigator: Cheng Wang — Gansu Provincial Maternal and Child Health Care Hospital
- Study coordinator: Yanxia Wang, Dr.
- Email: 1091771450@qq.com
- Phone: 86-0931-5188689
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.